Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis

Blood Purification

Volumn 18, Issue 1, 2000, Pages 50-54

  Nakamura, Tsukasa ^a   Ushiyama, Chifuyu ^a   Suzuki, Shingo ^a   Shimada, Noriaki ^b   Ebihara, Isao ^b   Suzaki, Masataka ^c   Takahashi, Toshimasa ^d   Koide, Hikaru ^b  

^a Misato Junshin Hospital   (Japan)

^b KOTO HOSPITAL   (Japan)

^c Ageo Central General Hospital   (Japan)

^d Renal Unit   (Japan)

Author keywords

Apheresis; Extracellular matrix; Growth factor; Hepatitis

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEPATITIS; ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATITIS; HUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

EID: 0033977477     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014407     Document Type: Article

References (17)

1. Michalopoulos GK: HGF and fulminant hepatitis. Jpn J Apheresis 1997;16:86-90.
2. Sekiyama KD, Toshiba M, Thomson AW: Circulating proinflammatory cytokines (IL-1β, TNF-α and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 1994;98:71-77.
3. Muzzillo DA, Imoto M, Fukuda Y, Koyama Y, Saga S, Nagai Y, Hayakawa T: Clinical evaluation of serum tissue inhibitor of metalloproteinase-1 levels in patients with liver diseases. J Gastroenterol Hepatol 1993;8:437-441.
4. Iwai H, Nagaki M, Naito T, Ishi Y, Murakami N, Sugihara T, et al: Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 1998;26: 873-876.
5. Tomiya T, Nagoshi S, Fujiwara K: Significance of serum human hepatocyte growth factor levels in patients with hepatic failure. Hepatology 1992;15:1-4.
6. Lawrence D: Identification and activation of latent transforming growth factor-β. Methods Enzymol 1991;198:327-336.
7. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T: Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases: An application for rheumatoid arthritis serum and plasma. J Immunol Methods 1990;127:103-108.
8. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N: Fulminant hepatic failure: Summary of a workshop. Hepatology 1995;21:240-252.
9. Kitamura M, Hida M, Hiraga S, Satoh T, Tanaka S, Kawamura Y, et al: Apheresis for fulminant hepatitis: Effects on clinical complications and prognosis. Jpn J Apheresis 1996; 15:35-39.
10. Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur MJP: Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci (Colch) 1995;89:75-81.
11. Fukuda Y, Imoto M, Koyama Y, Miyazawa Y, Nakano I, Hattori M, et al: Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers. Gastroenterol Jpn 1991;26:37-41.
12. Li T, Rosman AS, Leo MA, Nagai Y, Lieber CS: Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis. Hepatology 1994;19:1418-1423.
13. Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL: Immunolocalization studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo-and rheumatoid arthritis. Ann Rheum Dis 1995;54:25-32.
14. Yoshimura Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmci M: Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinase-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:969-975.
15. Akiyama K, Shikata K, Sugomoto H, Matsuda M, Shikata Y, Fujimoto N, Obata K, Matsui H, Makino H: Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis. Res Commun Mol Pathol Pharmacol 1997;95: 115-128.
16. Lotz M, Guerne PA: Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991;266:2017-2020.
17. Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM: Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. J Clin Invest 1992;289:19-27.